FDA approves therapy for ALS patients with rare gene mutation April 26, 2023 AutoBot Uncategorized 0 The FDA approved Qalsody (tofersen), a drug intended to treat amyotrophic lateral sclerosis with a rare mutation called the superoxide dismutase 1 gene, on April 25.